| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |